SCHEMBL4313787

SCHEMBL4313787

COCCOc1ccc(C=Cc2n[nH]c3ccccc23)c(N)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.44
GRM4 Q14833 1/20 0.40
CHEK1 O14757 4/20 0.40
FGFR1 P11362 2/20 0.39
NTRK1 P04629 2/20 0.39
NTRK3 Q16288 2/20 0.39
NTRK2 Q16620 2/20 0.39
LRRK2 Q5S007 4/20 0.38
ALDH1A1 P00352 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
FLT3 P36888 1/20 0.37
KDM4E B2RXH2 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
FLT1 P17948 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4313776 1.00 KDR (0.44) KDRGRM4CHEK1FGFR1NTRK1
SCHEMBL4315155 0.83 KDR (0.41) KDRGRM4CHEK1FGFR1NTRK1
SCHEMBL4315162 0.83 KDR (0.41) KDRGRM4CHEK1FGFR1NTRK1
SCHEMBL4313807 0.77 LMNA (0.39) KDRCHEK1FGFR1NTRK1NTRK3
SCHEMBL4313814 0.77 LMNA (0.39) KDRCHEK1FGFR1NTRK1NTRK3
SCHEMBL4317933 0.77 FGFR1 (0.42) FGFR1LRRK2FLT1
SCHEMBL4317941 0.77 FGFR1 (0.42) FGFR1LRRK2FLT1
SCHEMBL4320629 0.76 CHEK1 (0.42) KDRCHEK1FGFR1NTRK1NTRK2
SCHEMBL4320620 0.76 CHEK1 (0.42) KDRCHEK1FGFR1NTRK1NTRK2
SCHEMBL4308965 0.76 FGFR1 (0.44) KDRCHEK1FGFR1FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 KDR 75/4885GRM4 900/4885CHEK1 3274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.